Webinars

Insights from target to IND

Cutting-edge synthetic technology and expertise in special chemical matters have been centralized to form a variety of special chemistry platforms.

Science

Opportunities and Challenges for Treatments Delivered by Adeno-Associated Viruses

The word “rare” in the term rare disease can be confusing to the uninitiated. About 300 million people worldwide are living with one or more of over 6,000 rare diseases. This is just under 4% of the world population. So it’s not actually rare to have a rare disease.

Science

Enabling Technology for Targeted Protein Degradation

Identification and characterization of new bifunctional molecules including degraders using synergistic power of fragment and DEL screening, biophysics and structural biology

Magical Power of QM

To Empower Organic Syntheses

With powerful workstations, state of the art software, and our expertise on reaction QM analyses, real-time incorporations of such calculations in prospective analyses become routines in Research Service Division.

Science

Tumor Evolution Selectively Inactivates the Core Microrna Machinery for Immune Evasion

Bifunctional Molecules

A Diverse New Modality That Unlocks New Target Classes

Bifuctional molecules are opening up once-inaccessible targets and enabling development of drugs that are less susceptible to target protein mutations.